Mobile

A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Chronic Kidney Disease Subjects with Secondary Hyperparathyroidism Not Receiving Dialysis

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-004558-18

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy of cinacalcet compared with placebo by determining the proportion of subjects achieving a mean reduction of ≥ 30% in intact parathyroid hormone (iPTH) during the efficacy assessment phase.

Critère d'inclusion

  • Secondary Hyperparathyroidism in Chronic Kidney Disease subjects not receiving dialysis

Liens